NMR vs. STT: A Head-to-Head Stock Comparison

Updated on August 23, 2025

Here’s a clear look at NMR and STT, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

NMR trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, STT is a standard domestic listing.

Symbol	NMR	STT
Company Name	Nomura Holdings, Inc.	State Street Corporation
Country	Japan	United States
GICS Sector	Financials	Financials
GICS Industry	Capital Markets	Capital Markets
Market Capitalization	21.30 billion USD	31.74 billion USD
Exchange	NYSE	NYSE
Listing Date	December 17, 2001	March 17, 1980
Security Type	ADR	Common Stock

Historical Performance

This chart compares the performance of NMR and STT by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

NMR vs. STT: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	NMR	STT
5-Day Price Return	1.08%	-1.51%
13-Week Price Return	25.44%	13.85%
26-Week Price Return	3.96%	13.00%
52-Week Price Return	23.08%	38.12%
Month-to-Date Return	7.16%	0.13%
Year-to-Date Return	15.64%	14.00%
10-Day Avg. Volume	10.71M	1.53M
3-Month Avg. Volume	12.60M	2.01M
3-Month Volatility	20.12%	24.17%
Beta	1.48	1.51

Profitability

Return on Equity (TTM)

NMR

9.87%

Capital Markets Industry

Max: 38.97%
Q3: 21.61%
Median: 13.77%
Q1: 8.31%
Min: -4.25%

NMR’s Return on Equity of 9.87% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

STT

10.85%

Capital Markets Industry

Max: 38.97%
Q3: 21.61%
Median: 13.77%
Q1: 8.31%
Min: -4.25%

STT’s Return on Equity of 10.85% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

NMR vs. STT: A comparison of their Return on Equity (TTM) against the Capital Markets industry benchmark.

Net Profit Margin (TTM)

NMR

7.19%

Capital Markets Industry

Max: 66.67%
Q3: 35.11%
Median: 23.49%
Q1: 13.63%
Min: -15.18%

Falling into the lower quartile for the Capital Markets industry, NMR’s Net Profit Margin of 7.19% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

STT

20.50%

Capital Markets Industry

Max: 66.67%
Q3: 35.11%
Median: 23.49%
Q1: 13.63%
Min: -15.18%

STT’s Net Profit Margin of 20.50% is aligned with the median group of its peers in the Capital Markets industry. This indicates its ability to convert revenue into profit is typical for the sector.

NMR vs. STT: A comparison of their Net Profit Margin (TTM) against the Capital Markets industry benchmark.

Operating Profit Margin (TTM)

NMR

9.96%

Capital Markets Industry

Max: 86.40%
Q3: 46.46%
Median: 32.80%
Q1: 18.32%
Min: -21.87%

NMR’s Operating Profit Margin of 9.96% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

STT

24.96%

Capital Markets Industry

Max: 86.40%
Q3: 46.46%
Median: 32.80%
Q1: 18.32%
Min: -21.87%

STT’s Operating Profit Margin of 24.96% is around the midpoint for the Capital Markets industry, indicating that its efficiency in managing core business operations is typical for the sector.

NMR vs. STT: A comparison of their Operating Profit Margin (TTM) against the Capital Markets industry benchmark.

Profitability at a Glance

Symbol	NMR	STT
Return on Equity (TTM)	9.87%	10.85%
Return on Assets (TTM)	0.58%	0.79%
Net Profit Margin (TTM)	7.19%	20.50%
Operating Profit Margin (TTM)	9.96%	24.96%
Gross Profit Margin (TTM)	39.95%	--

Financial Strength

Current Ratio (MRQ)

NMR

0.23

Capital Markets Industry

Max: 3.76
Q3: 1.89
Median: 1.01
Q1: 0.54
Min: -0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

STT

Capital Markets Industry

Max: 3.76
Q3: 1.89
Median: 1.01
Q1: 0.54
Min: -0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

NMR vs. STT: A comparison of their Current Ratio (MRQ) against the Capital Markets industry benchmark.

Debt-to-Equity Ratio (MRQ)

NMR

10.44

Capital Markets Industry

Max: 6.62
Q3: 2.84
Median: 1.02
Q1: 0.32
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

STT

1.40

Capital Markets Industry

Max: 6.62
Q3: 2.84
Median: 1.02
Q1: 0.32
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

NMR vs. STT: A comparison of their Debt-to-Equity Ratio (MRQ) against the Capital Markets industry benchmark.

Interest Coverage Ratio (TTM)

NMR

Capital Markets Industry

Max: 126.03
Q3: 60.98
Median: 11.77
Q1: 4.95
Min: -36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

STT

Capital Markets Industry

Max: 126.03
Q3: 60.98
Median: 11.77
Q1: 4.95
Min: -36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

NMR vs. STT: A comparison of their Interest Coverage Ratio (TTM) against the Capital Markets industry benchmark.

Financial Strength at a Glance

Symbol	NMR	STT
Current Ratio (MRQ)	0.23	--
Quick Ratio (MRQ)	0.23	--
Debt-to-Equity Ratio (MRQ)	10.44	1.40
Interest Coverage Ratio (TTM)	--	--

Growth

Revenue Growth

NMR vs. STT: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

NMR vs. STT: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

NMR

3.55%

Capital Markets Industry

Max: 10.26%
Q3: 4.86%
Median: 2.78%
Q1: 1.22%
Min: 0.00%

NMR’s Dividend Yield of 3.55% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

STT

3.40%

Capital Markets Industry

Max: 10.26%
Q3: 4.86%
Median: 2.78%
Q1: 1.22%
Min: 0.00%

STT’s Dividend Yield of 3.40% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

NMR vs. STT: A comparison of their Dividend Yield (TTM) against the Capital Markets industry benchmark.

Dividend Payout Ratio (TTM)

NMR

66.06%

Capital Markets Industry

Max: 200.72%
Q3: 101.92%
Median: 57.97%
Q1: 32.36%
Min: 0.00%

NMR’s Dividend Payout Ratio of 66.06% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

STT

37.74%

Capital Markets Industry

Max: 200.72%
Q3: 101.92%
Median: 57.97%
Q1: 32.36%
Min: 0.00%

STT’s Dividend Payout Ratio of 37.74% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

NMR vs. STT: A comparison of their Dividend Payout Ratio (TTM) against the Capital Markets industry benchmark.

Dividend at a Glance

Symbol	NMR	STT
Dividend Yield (TTM)	3.55%	3.40%
Dividend Payout Ratio (TTM)	66.06%	37.74%

Valuation

Price-to-Earnings Ratio (TTM)

NMR

9.31

Capital Markets Industry

Max: 58.89
Q3: 31.00
Median: 18.54
Q1: 12.09
Min: 5.24

In the lower quartile for the Capital Markets industry, NMR’s P/E Ratio of 9.31 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

STT

11.09

Capital Markets Industry

Max: 58.89
Q3: 31.00
Median: 18.54
Q1: 12.09
Min: 5.24

In the lower quartile for the Capital Markets industry, STT’s P/E Ratio of 11.09 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

NMR vs. STT: A comparison of their Price-to-Earnings Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Sales Ratio (TTM)

NMR

0.67

Capital Markets Industry

Max: 14.49
Q3: 7.41
Median: 4.68
Q1: 2.25
Min: 0.04

In the lower quartile for the Capital Markets industry, NMR’s P/S Ratio of 0.67 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

STT

1.80

Capital Markets Industry

Max: 14.49
Q3: 7.41
Median: 4.68
Q1: 2.25
Min: 0.04

In the lower quartile for the Capital Markets industry, STT’s P/S Ratio of 1.80 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

NMR vs. STT: A comparison of their Price-to-Sales Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Book Ratio (MRQ)

NMR

0.83

Capital Markets Industry

Max: 9.48
Q3: 4.94
Median: 2.42
Q1: 1.21
Min: 0.38

NMR’s P/B Ratio of 0.83 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

STT

1.11

Capital Markets Industry

Max: 9.48
Q3: 4.94
Median: 2.42
Q1: 1.21
Min: 0.38

STT’s P/B Ratio of 1.11 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

NMR vs. STT: A comparison of their Price-to-Book Ratio (MRQ) against the Capital Markets industry benchmark.

Valuation at a Glance

Symbol	NMR	STT
Price-to-Earnings Ratio (TTM)	9.31	11.09
Price-to-Sales Ratio (TTM)	0.67	1.80
Price-to-Book Ratio (MRQ)	0.83	1.11
Price-to-Free Cash Flow Ratio (TTM)	3.32	6.81